Posted: 18 July 2023 Researchers have cracked how a particular type of immune cell develops in the body and protects against infection and disease. And the discovery could help in the development of more preventive treatments, according to…
Posted: 14 July 2023 In a world-first, a patient with an amputation above the elbow has been able to control a bionic hand as if it was his own thanks to new surgical and engineering advancements merging humans…
Posted: 13 July 2023 Pharmaceutical manufacturer IDT Australia is seeing a surge in sales as demand for medical cannabis products rises and companies seek out more capable contract development and manufacturing organisations (CDMO). The Melbourne company told investors…
Posted: 13 July 2023 A new cardiovascular research centre is bringing together Monash University, the Baker Heart and Diabetes Institute and Alfred Health to boost opportunities for academic-clinician partnered research and offer new pathways for emerging research talent in the Alfred Research Alliance Precinct.…
Posted: 13 July 2023 Monash University has acquired a prime Parkville property that will become a key addition to its Parkville campus – home to Monash’s world-leading Faculty of Pharmacy and Pharmaceutical Sciences – and significantly advance Australia’s…
Posted: 13 July 2023 Professor Mark Dawson, Head of Cancer Epigenetics Laboratory at Peter Mac has been awarded a Translational Research Program (TRP) grant worth USD $750,000 to further his research to help overcome acquired resistance to anti-cancer…
Posted: 11 July 2023 Atmo Biosciences, a company commercializing the world’s first ingestible gas-sensing capsule that provides insights into gut health and microbiome function, today announced results from a clinical study have found that its gas-sensing capsule can…
Posted: 10 July 2023 Dimerix Limited (ASX: DXB), a biopharmaceutical company with Phase 3 clinical studies in inflammatory diseases, today announced that the Paediatric Committee (PDCO) of the European Medicines Agency (EMA) accepted its Paediatric Investigation Plan (PIP)…
Posted: 7 July 2023 ASX Announcement Key points: New data favourably links AD-214 preclinical animal studies and Phase I human clinical trial results to provide important dose frequency insights AD-214 is designed to treat fibrotic diseases such as…
Posted: 4 July 2023 Australia’s newest biotech incubator is calling for innovative early-stage Australian biotechs to take up residency in its much-awaited Melbourne-based facility. The “Jumar Bioincubator” will be supported by cash and in-kind contributions of approximately $45 million over…
Posted: 4 July 2023 Dimerix Limited (ASX: DXB), a biopharmaceutical company with a Phase 3 clinical study in inflammatory disease, today confirmed that the Chinese regulatory agency, National Medical Products Administration (NMPA) has provided a written response on…
Posted: 4 July 2023 Neuren Pharmaceuticals (ASX: NEU) today announced that enrolment of subjects into its Phase 2 clinical trial of NNZ-2591 in Phelan-McDermid syndrome has now been completed. Topline results from the trial are expected to be…